Cholesterol Pathway Implicated in PARN Marrow Failure

Company Academic (Nature Communications) Event Type Peer-reviewed publication Modality Pathway pharmacology (cholesterol synthesis and ERK inhibition, preclinical) Asset Cholesterol biosynthesis inhibitors; trametinib (rescue experiments) Target HMGCR/SQLE pathway; ERK signaling Disease Area PARN-associated dyskeratosis congenita; marrow failure Summary A peer-reviewed Nature Communications paper published online November…

🔒

Continue reading this signal

Create a free InSilens account to unlock full articles, analysis, and deal context.

Create Free Account
Share this article :

Leave a Reply

Your email address will not be published. Required fields are marked *